Listed by the USPTO as BOECKELMAN, JACOB A
Tech Center 1600 • Art Units: 1628 1655
This examiner grants 35% of resolved cases
BOECKELMAN, JACOB A is assigned to tech center 1600 and art unit 1628. The profile records 262 resolved cases, a 34.7% allowance rate, a 47.3% interview lift, and a median of 1164 days to allowance. The interview figure is a substantial positive association within this examiner record despite the allowance rate.
The top companies are CJ CheilJedang Corporation, Nestlé S.A., and L'Oréal. The top firms are Morgan, Lewis & Bockius LLP (WA), Ipsilon USA - NLO, and MICHAEL BEST & FRIEDRICH LLP (Mke). Practitioners may use the company and firm history to locate comparable experience and to prioritize interview preparation.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18697375 | INJECTABLE BIOMATERIAL FOR DYSPHAGIA | Final Rejection | The Regents of the University of California |
| 18504646 | COMPOSITIONS INCLUDING FILAMENTOUS FUNGAL BIOMASS AND CULTURED ANIMAL CELLS, AND METHODS OF FORMING AND USING | Non-Final OA | The Regents of the University of California |
| 18936758 | EXTRACT FROM PLANT STEEPED IN ALLULOSE AND PREPARATION METHOD THEREFOR | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17920699 | BOWEL MOVEMENT IMPROVING COMPOSITION COMPRISING TENEBRIONIDAE LARVA EXTRACT | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17261168 | Engineered Exosomes for Medical Applications | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18702598 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIAL TISSUE | Final Rejection | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 17795604 | COMPOSITIONS AND METHODS FOR COATING BONE GRAFTS | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 18449980 | COMPOSITIONS AND METHODS UTILIZING SOUTHERN OCEAN MACKEREL OIL FOR PROVIDING HEALTH BENEFITS IN AN ANIMAL | Final Rejection | Société des Produits Nestlé S.A. |
| 17996649 | COMPOSITION COMPRISING FIBRE AND MULBERRY | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18557561 | DECELLULARIZED TISSUE HYDROGELS | Final Rejection | THE UNIVERSITY OF NOTTINGHAM |
| 17784253 | COMPOSITION COMPRISING AN EXTRACT OF ROSE BUSH SUCKER | Final Rejection | L'OREAL |
| 17621858 | USE OF A HYDRO-ALCOHOLIC EXTRACT OF EVENING PRIMROSE FOR HYDRATING SKIN AND INCREASING BARRIER FUNCTION | Non-Final OA | L'OREAL |
| 17798376 | COSMETIC COMPOSITION | Final Rejection | GIVAUDAN SA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy34.7% of resolved applications examined by Jacob A Boeckelman were allowed (262 resolved cases), compared with 25.9% across Art Unit 1628 over the last five years.
This examiner's interview lift is +47.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jacob A Boeckelman took 1,164 days on average from filing to allowance.
Jacob A Boeckelman examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).